Navigation Links
Experts discuss use of human stem cells in ape and monkey brains

Covering ship hulls with artificial shark skin could help ships sailing smoothly. The growth of marine organisms such as barnacles on ship hulls is a major cause of increased energy costs in the naval industry. Shark skin offers a structural design that prevents this so called 'bio-fouling'.

Ralph Liedert from the University of Applied Sciences, Bremen, Germany, is presenting his work on the application of artificial shark skin in a new anti-fouling strategy at the Society for Experimental Biology Annual Main Meeting in Barcelona [session A7.66].

Shark skin comprises scales that can flex individually from each other. Liedert produced a synthetic shark skin of elastic silicone, which has a significantly decreased contact surface.

This reduced contact surface makes it harder for barnacles to attach, and reduces fouling by 67%. When applied to the ship hull, this artificial surface enables ships to ´self-clean´, and a speed of 4-5 knots would remove all organisms attached with little adhesion.

Until recently, paints containing a biocide were used to prevent growth on submerged surfaces, but these were banned because of the the toxic effect of the highly toxic and unspecific biocide component on marine life.

As barnacles, mussels and algae cause up to 15% increase in the drag resistence of ships, this research is providing an alternative anti-fouling strategy of great importance.


'"/>

Source:


Page: 1

Related biology news :

1. End of deforestation in view? Experts advance new way to size up global forest resources
2. Scientists discuss improved biopesticides for locust control in West Africa
3. Dalai Lama, top scientists to discuss science & clinical applications of meditation
4. Novel technology detects human DNA mutations
5. Current human embryonic stem cell lines contaminated UCSD/Salk team finds
6. UWs Rosetta software to unlock secrets of many human proteins
7. Genome-wide mouse study yields link to human leukemia
8. Found: Missing sequence of the human Y chromosome
9. Study finds more than one-third of human genome regulated by RNA
10. Molecular machine may lead to new drugs to combat human diseases
11. Sea skate experiment sheds light on human cell transport
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/3/2017)... 2017  Data captured by IsoCode, IsoPlexis ... a statistically significant association between the potency ... and objective response of cancer patients post-treatment. ... whether cancer patients will respond to CAR-T ... as to improve both pre-infusion potency testing and ...
(Date:3/29/2017)... -- higi, the health IT company that operates the largest ... , today announced a Series B investment from BlueCross ... new investment and acquisition accelerates higi,s strategy to create ... health activities through the collection and workflow integration of ... and secures data today on behalf of over 36 ...
(Date:3/24/2017)... DUBLIN , Mar 24, 2017 Research ... Vehicle Access System Market Analysis & Trends - Industry Forecast to ... ... poised to grow at a CAGR of around 15.1% over the ... This industry report analyzes the market estimates and forecasts for ...
Breaking Biology News(10 mins):
(Date:10/9/2017)... Oct. 9, 2017  BioTech Holdings announced today ... which its ProCell stem cell therapy prevents limb ... The Company, demonstrated that treatment with ProCell resulted ... saved as compared to standard bone marrow stem ... resulted in reduction of therapeutic effect.  ...
(Date:10/9/2017)... , ... October 09, 2017 , ... ... four-tiered line of medical marijuana products targeting the needs of consumers who are ... of Kindred takes place in Phoenix, Arizona. , As operators of two successful ...
(Date:10/7/2017)... ... October 06, 2017 , ... ... technologies, launched its ProxiMeta™ Hi-C metagenome deconvolution product, featuring the first commercially ... cloud-based bioinformatics software to perform Hi-C metagenome deconvolution using their own facilities, ...
(Date:10/6/2017)... ... 06, 2017 , ... On Tuesday, October 24th, ABC² (Accelerate ... first-ever adaptive clinical trial for glioblastoma (GBM). The featured speaker will be Dr. ... open to the public, but registration is required. , WHAT: ABC² Brain ...
Breaking Biology Technology: